Skip to content

About
Program
Venture Advisors
Advisory Board

ELabNYC Participant

Sort

Year

All2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-2020

Affiliation

AllAlbert Einstein College of MedicineBioLabsCold Spring Harbor LaboratoryColumbia Business SchoolColumbia UniversityCornell UniversityCUNY City College of New YorkCUNY City University of New YorkCUNY Graduate School of Public Health & Health PolicyCUNY Hunter CollegeHospital for Special SurgeryLong Island UniversityMemorial Sloan Kettering Cancer Center (MSKCC)Mount SinaiNew York Institute of TechnologyNew York UniversityNew York University Tandon Veterans Future LabPrinceton Innovation CenterRockefeller UniversityState University of New YorkStevens Institute of TechnologyThe New York Genome CenterUniversity of IllinoisVictoria University of Wellington, New ZealandWeill Cornell MedicineWright State UniversityYale University

Technology

AllBioinformaticsDiagnosticDigital HealthMaterialsMedical DeviceNutraceutical, Functional FoodPharmaceutical DrugPharmaceutical Waste ManagementResearch ToolTherapeutic

Indication

AllAge-Related Sensory LossAI-based medical dictation softwareAllergy/AsthmaAutoimmune & InflammationBasic ResearchBiologicBiomaterialsBrain-Computer InterfaceCardiovascular DiseaseCentral Nervous System DisordersClinical Decision SupportClinical Decision Support and Physician EducationClinical ResearchClinical TrialsData VisualizationDeep Brain StimulationDentistryDermatologyDevelopmental DisordersDisease SurveillanceDrug DeliveryDrug Delivery Mechanism including SoftwareDrug Delivery Mechanism utilizing APIsDrug DiscoveryEducationEnvironmental ImpactEpigenomicsFibrosisFluorescence ApplicationsFunctional ProstheticsGenetics & GenomicsGut MicrobiomeHealth Data AnalyticsHealthcare ManagementHematologyHuman Monoclonal AntibodiesImmunologyInfectious DiseaseLow-Cost Spin Coater kitsMaternal HealthMedical ImagingMenstrual HealthMetabolic DiseaseMobile application platform (software) Education,Mobile Health ApplicationsMolecular DiagnosticMusculoskeletal DisordersNanotechnologyNephrologyNeurodegenerative DiseaseNeuromodulationNutritionObesityOccupational TherapyOncologyOphthalmologyOrphan DiseasesOrthopaedicsPain ManagementPerformance EnhancementPersonalized MedicinePharmaceutical Supply Chain ManagementPharmaceutical Waste ManagementPharmacoeconomicsPhysical TherapyPlatform TechnologyPregnant WomenRegenerative MedicineResearch ToolsRespiratory DiseaseSensory Processing DisorderSkin DiseasesSocial ImpactSoftwareSpeech TherapySurgical ToolTechnology PlatformWearable assistive technologyWireless Health (e.g., Remote Monitoring, Portable Diagnostic Devices)Women's healthWound Care and Wound Treatment

Attributes

AllMinority OwnedWomen Owned

Dong Zhang

dong1

ALT therapeutics

2019-2020

Affiliations

New York Institute of Technology

Technologies

Therapeutic

Indication

Oncology

Executive Summary

Website

www.linkedin.com

We discovered that inhibition of FANCM prevents the survival of ALT cancers (10-15% of cancers) and planned to develop FANCM inhibitors to treat ALT cancers.

2020 PITCH DAY VIDEO

Sort

Year

All2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-2020

Affiliation

AllAlbert Einstein College of MedicineBioLabsCold Spring Harbor LaboratoryColumbia Business SchoolColumbia UniversityCornell UniversityCUNY City College of New YorkCUNY City University of New YorkCUNY Graduate School of Public Health & Health PolicyCUNY Hunter CollegeHospital for Special SurgeryLong Island UniversityMemorial Sloan Kettering Cancer Center (MSKCC)Mount SinaiNew York Institute of TechnologyNew York UniversityNew York University Tandon Veterans Future LabPrinceton Innovation CenterRockefeller UniversityState University of New YorkStevens Institute of TechnologyThe New York Genome CenterUniversity of IllinoisVictoria University of Wellington, New ZealandWeill Cornell MedicineWright State UniversityYale University

Technology

AllBioinformaticsDiagnosticDigital HealthMaterialsMedical DeviceNutraceutical, Functional FoodPharmaceutical DrugPharmaceutical Waste ManagementResearch ToolTherapeutic

Indication

AllAge-Related Sensory LossAI-based medical dictation softwareAllergy/AsthmaAutoimmune & InflammationBasic ResearchBiologicBiomaterialsBrain-Computer InterfaceCardiovascular DiseaseCentral Nervous System DisordersClinical Decision SupportClinical Decision Support and Physician EducationClinical ResearchClinical TrialsData VisualizationDeep Brain StimulationDentistryDermatologyDevelopmental DisordersDisease SurveillanceDrug DeliveryDrug Delivery Mechanism including SoftwareDrug Delivery Mechanism utilizing APIsDrug DiscoveryEducationEnvironmental ImpactEpigenomicsFibrosisFluorescence ApplicationsFunctional ProstheticsGenetics & GenomicsGut MicrobiomeHealth Data AnalyticsHealthcare ManagementHematologyHuman Monoclonal AntibodiesImmunologyInfectious DiseaseLow-Cost Spin Coater kitsMaternal HealthMedical ImagingMenstrual HealthMetabolic DiseaseMobile application platform (software) Education,Mobile Health ApplicationsMolecular DiagnosticMusculoskeletal DisordersNanotechnologyNephrologyNeurodegenerative DiseaseNeuromodulationNutritionObesityOccupational TherapyOncologyOphthalmologyOrphan DiseasesOrthopaedicsPain ManagementPerformance EnhancementPersonalized MedicinePharmaceutical Supply Chain ManagementPharmaceutical Waste ManagementPharmacoeconomicsPhysical TherapyPlatform TechnologyPregnant WomenRegenerative MedicineResearch ToolsRespiratory DiseaseSensory Processing DisorderSkin DiseasesSocial ImpactSoftwareSpeech TherapySurgical ToolTechnology PlatformWearable assistive technologyWireless Health (e.g., Remote Monitoring, Portable Diagnostic Devices)Women's healthWound Care and Wound Treatment

Attributes

AllMinority OwnedWomen Owned

Newsletter Signup

Name
First Last
Email*
CAPTCHA

Corporate Supporters

© 2024 ELabNYC | Powered by Beaver Builder